U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H27ClFN3O2
Molecular Weight 383.888
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ULIXACALTAMIDE

SMILES

CC(C)(C)NC(=O)CN1CCC(CNC(=O)C2=CC(Cl)=CC(F)=C2)CC1

InChI

InChIKey=JOCLITFYIMJMNK-UHFFFAOYSA-N
InChI=1S/C19H27ClFN3O2/c1-19(2,3)23-17(25)12-24-6-4-13(5-7-24)11-22-18(26)14-8-15(20)10-16(21)9-14/h8-10,13H,4-7,11-12H2,1-3H3,(H,22,26)(H,23,25)

HIDE SMILES / InChI

Approval Year

PubMed

PubMed

TitleDatePubMed
T-type calcium channel blockers that attenuate thalamic burst firing and suppress absence seizures.
2012 Feb 15
Patents
Name Type Language
ULIXACALTAMIDE
INN  
Official Name English
1-PIPERIDINEACETAMIDE, 4-(((3-CHLORO-5-FLUOROBENZOYL)AMINO)METHYL)-N-(1,1-DIMETHYLETHYL)-
Systematic Name English
ulixacaltamide [INN]
Common Name English
4-(((3-CHLORO-5-FLUOROBENZOYL)AMINO)METHYL)-N-(1,1-DIMETHYLETHYL)-1-PIPERIDINEACETAMIDE
Systematic Name English
Code System Code Type Description
INN
12064
Created by admin on Sat Dec 16 18:53:06 GMT 2023 , Edited by admin on Sat Dec 16 18:53:06 GMT 2023
PRIMARY
CAS
1199236-64-0
Created by admin on Sat Dec 16 18:53:06 GMT 2023 , Edited by admin on Sat Dec 16 18:53:06 GMT 2023
PRIMARY
NCI_THESAURUS
C188619
Created by admin on Sat Dec 16 18:53:06 GMT 2023 , Edited by admin on Sat Dec 16 18:53:06 GMT 2023
PRIMARY
FDA UNII
QT2PJH89C3
Created by admin on Sat Dec 16 18:53:06 GMT 2023 , Edited by admin on Sat Dec 16 18:53:06 GMT 2023
PRIMARY
PUBCHEM
44540045
Created by admin on Sat Dec 16 18:53:06 GMT 2023 , Edited by admin on Sat Dec 16 18:53:06 GMT 2023
PRIMARY
EPA CompTox
DTXSID60659275
Created by admin on Sat Dec 16 18:53:06 GMT 2023 , Edited by admin on Sat Dec 16 18:53:06 GMT 2023
PRIMARY
SMS_ID
300000042091
Created by admin on Sat Dec 16 18:53:06 GMT 2023 , Edited by admin on Sat Dec 16 18:53:06 GMT 2023
PRIMARY